Genpact LTD (G) stock analysis
Close on Nov 11, 2026Market cap $7.33BP/E 12.7Yield 1.56%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid21 of 30 checks passed
Genpact passes 21 of the 30 checks behind our score; 1 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 5/6
- Growth
- 3/6
- Past performance
- 6/6
- Financial health
- 4/6
- Dividend
- 3/6
What stands out
Margin of safety over 20%
The price is 21.2% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $43.60 is below our fair value estimate of $55.36.
Return on equity over 15%
Return on equity was 22.4% over the last twelve months and averaged 22.9% over five years.
Return on capital over 10%
Return on invested capital was 19.1%, above the 10% that usually covers the cost of capital.
What to watch
High debt
Debt is 43.3% of shareholders' equity, above the 40% we consider low.
Revenue growing under 10% a year
Revenue grew 5.1% a year over the last three fiscal years, short of the 10% we look for.
Earnings growth not accelerating
Net income grew 6.7% over the last twelve months, against a 5-year average of 12.4% a year.
Dividend was cut
The dividend per share fell by more than 10% at least once in the last 10 fiscal years.
Valuation5/6
P/E below its 5-year median
Genpact's P/E of 12.7 is below its own 5-year median of 15.0.
P/E below the industry
Genpact's P/E of 12.7 is below the Management and Public Relations Services median of 21.9.
EV/EBITDA below its 5-year median
Genpact's EV/EBITDA of 10.0 is below its 5-year median of 12.1.
P/B above the industry
Genpact's price-to-book of 2.70 is above the Management and Public Relations Services median of 2.31.
Trading below fair value
The share price of $43.60 is below our fair value estimate of $55.36.
Margin of safety over 20%
The price is 21.2% below fair value, more than the 20% cushion we look for.
Growth3/6
Revenue growing under 10% a year
Revenue grew 5.1% a year over the last three fiscal years, short of the 10% we look for.
EPS growing 10%+ a year
Diluted EPS grew 18.5% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew 6.7% over the last twelve months, against a 5-year average of 12.4% a year.
Growing slower than the industry
Revenue grew 6.7% over the last twelve months; the Management and Public Relations Services median is 7.2%.
Guidance raised
Genpact raised its full year 2026 Adjusted diluted earnings per share growth outlook on Aug 6, 2026.
Gross margin improving
Gross margin was 36.9% over the last twelve months, against 35.8% a year earlier.
Past performance6/6
Return on equity over 15%
Return on equity was 22.4% over the last twelve months and averaged 22.9% over five years.
Return on capital over 10%
Return on invested capital was 19.1%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Genpact's return on equity of 22.4% is above the Management and Public Relations Services median of 0.4%.
Earnings grew over 5 years
Net income grew 12.4% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 11.0% over the last twelve months, against a 5-year average of 10.6%.
Net margin above the industry
Genpact's net margin of 11.0% is above the Management and Public Relations Services median of 0.2%.
Financial health4/6
High debt
Debt is 43.3% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 86.7% five years ago to 43.3%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 36.5% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 1.95 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 3.55; above 3 is the safe zone and below 1.8 the distress zone.
Dividend3/6
Pays a dividend
Genpact paid dividends worth 1.3% of the share price over the last twelve months.
Yield below Treasuries
The 1.3% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Genpact yields 1.3%.
Dividend was cut
The dividend per share fell by more than 10% at least once in the last 10 fiscal years.
Covered by earnings
Dividends take 21.0% of net income.
Covered by free cash flow
Dividends take 34.7% of free cash flow.
Fair value
How we estimate itOur estimate per share
$55.36
The share price is 21% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 18.4× | 15.0× | 21.9× | $63.21 | 40% |
| EV/EBITDA | 12.5× | 12.1× | 12.9× | $55.31 | 35% |
| P/B | 2.8× | 3.2× | 2.3× | $44.76 | 10% |
| Earnings power | 8.1% cost of equity | – | – | $41.64 | 15% |
| Fair value | $55.36 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 15.0
- Management and Public Relations Services median 21.9
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $77.66M
- Value traded per 1% price move
- $44.02M
Downside
Medium risk
- Typical loss in a bad month
- 20.0%
- Volatility (annualized)
- 38%
- Sharpe ratio, 1 year
- -0.16
- Beta to the S&P 500 (5Y)
- 0.65
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +6.6% | +5.1% | +6.5% | +7.5% | |
| Gross profit | +8.3% | +6.0% | +7.2% | +6.6% | |
| Operating income | +6.9% | +14.3% | +11.3% | +8.4% | |
| Net income | +7.6% | +16.1% | +12.4% | +8.7% | |
| EPS, diluted | +9.8% | +18.5% | +14.8% | +11.1% | |
| Free cash flow | +37.9% | +23.2% | +7.4% | +10.7% | |
| Dividend per share | +11.5% | +10.8% | +11.8% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 20.8% | 17.5% | 22.4% | |
| Return on assets | 9.5% | 6.6% | 10.2% | |
| Current ratio | 1.68 | 1.45 | 1.66 | |
| Debt to equity | 0.70 | 0.87 | 0.60 | |
| Interest coverage | – | – | – | |
| Capex to revenue | 3.2% | 1.9% | 1.5% | |
| Diluted shares | 210M | 196M | 177M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Genpact generated $3.06B from operations and spent $1.81B on capital expenditure, dividends and share buybacks. 18% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 10.9% | 0.94× | 2.19× | 22.4% |
| FY2024 | 10.8% | 0.97× | 2.11× | 22.2% |
| FY2023 | 14.1% | 0.95× | 2.31× | 31.0% |
| FY2022 | 8.1% | 0.91× | 2.57× | 19.0% |
| FY2021 | 9.2% | 0.82× | 2.64× | 19.8% |
| FY2020 | 8.3% | 0.80× | 2.65× | 17.5% |
| FY2019 | 8.7% | 0.88× | 2.58× | 19.7% |
| FY2018 | 9.4% | 0.86× | 2.47× | 19.9% |
| FY2017 | 9.6% | 0.86× | 2.34× | 19.4% |
| FY2016 | 10.5% | 0.91× | 2.19× | 20.8% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$552.49M
- Cash generatingOperating cash flow above zero$812.86M
- Return on assets improvedROA up on the prior year10.7% → 11.1%
- Earnings backed by cashOperating cash flow above net income$812.86M vs $552.49M
- Less leverageLong-term debt to assets fell24.0% → 20.0%
- Better liquidityCurrent ratio rose2.16 → 1.66
- No dilutionShare count did not rise180M → 177M
- Gross margin improvedGross margin up on the prior year35.45% → 36.04%
- More efficientAsset turnover rose0.99 → 1.02
See a number that looks wrong?